January 13, 2010 (Miami, Florida) — Aerosolized bronchodilators are independently associated with an increased risk for ventilator-associated pneumonia (VAP) in critically ill patients, according to ...

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

August 16, 2010 — Nebulized hypertonic 3% saline solution without adjunctive bronchodilators has a low rate of adverse events in infants younger than 2 years with bronchiolitis, according to the ...

A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with ...

A bronchodilator is a medication that relaxes and opens the airways, or bronchi, in the lungs. A doctor may prescribe them for asthma and other respiratory conditions. Narrowed airways make it ...

A study of Korean patients with chronic obstructive pulmonary disease (COPD) found that a paradoxical response to short-acting bronchodilators may reduce lung function and quality of life. The study ...

COPD can be managed with medications like bronchodilators and corticosteroids, which reduce airway inflammation and open airways for easier breathing. Vaccines for the flu, pneumonia, shingles, RSV, ...

Novartis' dual combination bronchodilator Utibron Neohaler inhalation powder for patients with chronic obstructive pulmonary disease (COPD) has received FDA approval. It is not indicated to treat ...

Short-acting bronchodilators offer quick relief of respiratory symptoms, with effects lasting from 30 minutes to several hours. They are often used as a rescue medication. Long-acting bronchodilators ...

Patients with COPD also have a high prevalence of CVD. Bronchodilators prescribed for symptomatic COPD control may also contribute to cardiovascular risk. In accordance with treatment guidelines, most ...